Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tinzaparin sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,7 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,9 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,35 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,45 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
|
Product containing precisely tinzaparin sodium 40000 unit/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 40000 unit/2 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 2500 unit/0.25 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 2500 unit/0.25 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 3500 unit/0.35 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 3500 unit/0.35 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 4500 unit/0.45 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 4500 unit/0.45 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 10000 unit/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 10000 unit/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 14000 unit/0.7 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 14000 unit/0.7 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 18000 unit/0.9 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 18000 unit/0.9 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 20000 unit/2 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 20000 unit/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tinzaparin sodium (substance) |
Inferred relationship |
Some |
1 |